Absci Corporation (ABSI) Insider Trading Activity

NASDAQ$2.55
Market Cap
$383.45M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
182 of 888
Rank in Industry
106 of 508

ABSI Insider Trading Activity

ABSI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$582,588
4
67
Sells
$132,328
2
33

Related Transactions

Pangalos Menelas Ndirector
1
$254,788
0
$0
$254,788
Busch AndreasChief Innovation Officer
1
$152,000
0
$0
$152,000
VAN HOUTEN FRANSdirector
1
$148,800
0
$0
$148,800
Bedrick ToddSVP, CAO
1
$27,000
0
$0
$27,000
Jonasson ZachariahCFO / CBO
0
$0
1
$52,313
$-52,313
McClain SeanChief Executive Officer
0
$0
1
$80,015
$-80,015

About Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Insider Activity of Absci Corporation

Over the last 12 months, insiders at Absci Corporation have bought $582,588 and sold $132,328 worth of Absci Corporation stock.

On average, over the past 5 years, insiders at Absci Corporation have bought $27.42M and sold $6.94M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Pangalos Menelas N (director) — $254,788. Busch Andreas (Chief Innovation Officer) — $152,000. VAN HOUTEN FRANS (director) — $148,800.

The last purchase of 40,000 shares for transaction amount of $148,800 was made by VAN HOUTEN FRANS (director) on 2025‑12‑05.

List of Insider Buy and Sell Transactions, Absci Corporation

2026-02-02SaleMcClain SeanChief Executive Officer
26,761
0.0176%
$2.99
$80,015
-13.66%
2026-02-02SaleJonasson ZachariahCFO / CBO
17,496
0.0115%
$2.99
$52,313
-13.66%
2025-12-05PurchaseVAN HOUTEN FRANSdirector
40,000
0.0276%
$3.72
$148,800
-6.01%
2025-09-22PurchaseBedrick ToddSVP, CAO
10,000
0.0067%
$2.70
$27,000
+25.84%
2025-09-22PurchasePangalos Menelas Ndirector
95,785
0.0633%
$2.66
$254,788
+25.84%
2025-07-28PurchaseBusch AndreasChief Innovation Officer
50,000
0.0401%
$3.04
$152,000
+2.69%
2024-06-13SaleJonasson ZachariahCFO / CBO
19,859
0.0194%
$4.98
$98,892
-21.85%
2024-05-22SalePhoenix Venture Partners II LP10 percent owner
3.1M
2.6164%
$4.40
$13.64M
-19.85%
2024-03-01PurchaseRedmile Group, LLCdirector
222,222
0.1982%
$4.50
$999,999
-24.91%
2022-02-09PurchaseKorman SarahGeneral Counsel
4,250
0.0044%
$7.96
$33,830
-59.91%
2022-01-20PurchaseBedrick ToddVP, CCPAO
2,000
0.0023%
$7.50
$15,000
-50.42%
2022-01-19PurchaseMcClain SeanPresident and Chief Executive
7,155
0.0081%
$6.92
$49,513
-47.79%
2021-07-26PurchaseRedmile Group, LLCdirector
1.88M
1.7426%
$16.00
$30M
-63.43%
2021-07-26PurchaseCasdin Partners Master Fund, L.P.director
1.56M
1.4521%
$16.00
$25M
-63.43%
2021-07-26PurchaseCasdin Elidirector
1.56M
1.4521%
$16.00
$25M
-63.43%
2021-07-26PurchaseMcClain SeanPresident and Chief Executive
600
0.0006%
$16.00
$9,600
-63.43%
2021-07-26PurchaseMCGINNIS KAREN Kdirector
15,000
0.0139%
$16.00
$240,000
-63.43%
2021-07-26PurchaseKorman SarahGeneral Counsel
10,000
0.0093%
$16.00
$160,000
-63.43%
2021-07-26PurchaseJonasson Zachariahdirector
9,000
0.0084%
$16.00
$144,000
-63.43%
2021-07-26PurchaseBedrick ToddVP, CCPAO
1,000
0.0009%
$16.00
$16,000
-63.43%
Total: 20
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
McClain SeanChief Executive Officer
8334567
5.5426%
$21.25M21
<0.0001%
Jonasson ZachariahCFO / CBO
383538
0.2551%
$978,021.9012
<0.0001%
Busch AndreasChief Innovation Officer
327264
0.2176%
$834,523.2010
Bedrick ToddSVP, CAO
180428
0.12%
$460,091.4030
<0.0001%
Pangalos Menelas Ndirector
113960
0.0758%
$290,598.0010
VAN HOUTEN FRANSdirector
63320
0.0421%
$161,466.0010
Phoenix Venture Partners II LP10 percent owner
11279522
7.5011%
$28.76M01
Redmile Group, LLCdirector
8253316
5.4886%
$21.05M20
<0.0001%
Casdin Elidirector
6745333
4.4858%
$17.2M10
<0.0001%
Casdin Partners Master Fund, L.P.director
6745333
4.4858%
$17.2M10
<0.0001%
MCGINNIS KAREN Kdirector
15000
0.01%
$38,250.0010
<0.0001%
Korman SarahGeneral Counsel
14250
0.0095%
$36,337.5020
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$26,922,905
100
5.55%
$356.07M
$5,960,789
91
-7.17%
$371.99M
$54,836,085
68
-0.52%
$382.34M
$17,468,215
46
18.85%
$444.22M
$130,095
43
45.19%
$364.2M
$24,384,691
42
-30.27%
$399.81M
$74,231,875
30
40.62%
$415.83M
$104,137,421
15
21.28%
$353.89M
$65,355,913
13
-3.42%
$353.71M
Absci Corporation
(ABSI)
$81,667,942
12
-57.54%
$383.45M
$57,263,116
11
-8.37%
$404.51M
$112,952,085
11
-19.19%
$363.07M
$14,995,689
8
3.76%
$359.97M
$603,645
8
57.40%
$402.24M
$166,385
7
-23.62%
$452.24M
$43,326,461
6
16.01%
$442.74M
$4,745,999
5
-4.91%
$395.34M
$12,035,408
5
-37.54%
$370.62M
$3,850,000
1
-51.32%
$404.48M

ABSI Institutional Investors: Active Positions

Increased Positions80+60.61%16M+18.19%
Decreased Positions50-37.88%9M-10.32%
New Positions33New4MNew
Sold Out Positions14Sold Out883,938Sold Out
Total Postitions162+22.73%98M+7.88%

ABSI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fmr Llc$79,721.0014.72%22.08M+3M+15.42%2025-09-30
Ark Investment Management Llc$43,908.008.11%12.16M+2M+21.07%2025-09-30
Blackrock, Inc.$38,205.007.06%10.58M+2M+26.58%2025-09-30
Redmile Group, Llc$29,794.005.5%8.25M00%2025-09-30
Vanguard Group Inc$26,288.004.86%7.28M+830,336+12.87%2025-09-30
Ameriprise Financial Inc$11,520.002.13%3.19M+625,451+24.38%2025-09-30
Geode Capital Management, Llc$11,021.002.04%3.05M+607,465+24.84%2025-09-30
Massachusetts Financial Services Co /Ma/$7,972.001.47%2.21M-18,778-0.84%2025-09-30
State Street Corp$7,454.001.38%2.06M+261,876+14.52%2025-09-30
Heights Capital Management, Inc$7,222.001.33%2M+2MNew2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.